Jones Huw G, Rees Michael, Aboumarzouk Omar M, Brown Joshua, Cragg James, Billings Peter, Carter Ben, Chandran Palanichamy
Department of Colorectal Surgery, Singleton Hospital, ABM University NHS Trust, Sketty Lane, Swansea, UK, SA2 8QA.
Cochrane Database Syst Rev. 2018 Jul 20;7(7):CD008905. doi: 10.1002/14651858.CD008905.pub3.
Parastomal herniation is a common problem following formation of a stoma after both elective and emergency abdominal surgery. Symptomatic hernias give rise to a significant amount of patient morbidity, and in some cases mortality, and therefore may necessitate surgical treatment to repair the hernial defect and/or re-site the stoma. In an effort to reduce this complication, recent research has focused on the application of a synthetic or biological mesh, inserted during stoma formation to help strengthen the abdominal wall.
The primary objective was to evaluate whether mesh reinforcement during stoma formation reduces the incidence of parastomal herniation. Secondary objectives included the safety or potential harms or both of mesh placement in terms of stoma-related infections, mesh-related infections, patient-reported symptoms/postoperative quality of life, and re-hospitalisation/ambulatory visits.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library 2018, Issue 1), Ovid MEDLINE (1970 to 11 January 2018), Ovid Embase (1974 to 11 January 2018), and Science Citation Index Expanded (1970 to 11 January 2018). To identify ongoing studies, we also searched the metaRegister of Controlled Trials (mRCT) on 11 January 2018.
We considered for inclusion all randomised controlled trials (RCTs) of prosthetic mesh (including biological/composite mesh) placement versus a control group (no mesh) for the prevention of parastomal hernia.
Two review authors independently assessed the studies identified by the literature search for potential eligibility. We obtained the full articles for all studies that potentially met the inclusion criteria and included all those that met the criteria. Any differences in opinion between review authors were resolved by consensus. We pooled study data into a meta-analysis. We assessed heterogeneity by calculation of I and expressed results for each variable as a risk ratio (RR) with corresponding 95% confidence intervals (CI). We expressed continous outcomes as mean difference (MD) with corresponding 95% CIs.
We included 10 RCTs involving a total of 844 participants. The primary outcome was overall incidence of parastomal herniation. Secondary outcomes were rate of reoperation at 12 months, operative time, postoperative length of hospital stay, stoma-related infections, mesh-related infections, quality of life, and rehospitalisation rate. We judged the risk of bias across all domains to be low in six trials. We judged four trials to have an overall high risk of bias.The overall incidence of parastomal hernia was less in participants receiving a prophylactic mesh compared to those who had a standard ostomy formation (RR 0.53, 95% CI 0.43 to 0.66; 10 studies, 771 participants; I = 69%; low-quality evidence). In absolute numbers, the incidence of parastomal hernia was 22 per 100 participants (18 to 27) receiving prophylactic mesh compared to 41 per 100 participants having a standard ostomy formation.There were no differences in the need for reoperation (RR 0.90, 95% CI 0.50 to 1.64; 9 studies, 757 participants; I = 0%; low-quality evidence); operative time (MD -6.50 (min), 95% CI -18.24 to 5.24; 6 studies, 671 participants; low-quality evidence); postoperative length of hospital stay (MD -0.95 (days), 95% CI -2.03 to 0.70; 4 studies, 500 participants; moderate-quality evidence); or stoma-related infections (RR 0.89, 95% CI 0.32 to 2.50; 6 studies, 472 participants; I = 0%; low-quality evidence) between the two groups.We were unable to analyse mesh-related infections, quality of life, and rehospitalisation rate due to sparse data or because the outcome was not reported in the included studies.
AUTHORS' CONCLUSIONS: This Cochrane Review included 10 RCTs with a total of 844 participants. The review demonstrated a reduction in the incidence of parastomal hernia in people who had a prophylactic synthetic mesh placed at the time of the index operation compared to a standard ostomy formation. However, our confidence in this estimate is low due to the presence of a large degree of clinical heterogeneity, as well as high variability in follow-up duration and technique of parastomal herniation detection. We found the rate of stoma-related infection to be similar in both the intervention and control groups.
造口旁疝是择期和急诊腹部手术后造口形成后的常见问题。有症状的疝会导致大量患者发病,在某些情况下还会导致死亡,因此可能需要手术治疗以修复疝缺损和/或重新安置造口。为了减少这种并发症,最近的研究集中在造口形成期间应用合成或生物补片,以帮助加强腹壁。
主要目的是评估造口形成期间补片加固是否能降低造口旁疝的发生率。次要目的包括补片放置在造口相关感染、补片相关感染、患者报告的症状/术后生活质量以及再次住院/门诊就诊方面的安全性或潜在危害或两者。
我们检索了Cochrane对照试验中心注册库(CENTRAL;Cochrane图书馆2018年第1期)、Ovid MEDLINE(1970年至2018年1月11日)、Ovid Embase(1974年至2018年1月11日)和科学引文索引扩展版(1970年至2018年1月11日)。为了识别正在进行的研究,我们还于2018年1月11日检索了对照试验元注册库(mRCT)。
我们纳入了所有比较放置人工补片(包括生物/复合补片)与对照组(不放置补片)预防造口旁疝的随机对照试验(RCT)。
两位综述作者独立评估文献检索中识别出的研究的潜在适用性。我们获取了所有可能符合纳入标准的研究的全文,并纳入了所有符合标准的研究。综述作者之间的任何意见分歧通过协商解决。我们将研究数据汇总进行荟萃分析。我们通过计算I2评估异质性,并将每个变量的结果表示为风险比(RR)及相应的95%置信区间(CI)。我们将连续结果表示为平均差(MD)及相应的9